Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:52:06.513Z.
Calculation as of: 2026-10-06T14:52:06.513Z.
Quote observation: 2026-10-06T14:50:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1e37222dd90dbab5e03bfa1bbf20eaf6e61690ec1e62f49524765e66f30de265
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Filana Therapeutics, Inc.
Market Cap
$41.84M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.69M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.63M
Operating Cash Flow Yield
N/A
TTM Avg
4.07%
3Y Avg
3.32%
5Y Avg
3.32%
Market Cap
$44.80M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.67M
Operating Cash Flow Yield
N/A
TTM Avg
11.87%
3Y Avg
9.02%
5Y Avg
6.85%
Market Cap
$38.71M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.52M
Operating Cash Flow Yield
1.68%
TTM Avg
21.41%
3Y Avg
13.95%
5Y Avg
10.59%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $41.84M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $41.66M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.69M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $39.63M | N/A | 4.07% | 3.32% | 3.32% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.80M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $44.67M | N/A | 11.87% | 9.02% | 6.85% |
| Incannex Healthcare Limited (IXHL)vs › | $38.71M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | 1.68% | 21.41% | 13.95% | 10.59% |
| DarioHealth Corp. (DRIO)vs › | $45.32M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
